These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9745257)

  • 1. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
    Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of dynamic susceptibility contrast MRI using echo-planar imaging in differential diagnosis of breast tumors].
    Yoshino A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):441-6. PubMed ID: 9745258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of contrast-enhanced breast MR imaging.
    Piccoli CW
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):557-71. PubMed ID: 7489308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic fibrous mastopathy: dynamic contrast-enhanced magnetic resonance imaging findings.
    Tuncbilek N; Karakas HM; Okten O
    Breast J; 2004; 10(4):359-62. PubMed ID: 15239797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
    Orel SG; Schnall MD; LiVolsi VA; Troupin RH
    Radiology; 1994 Feb; 190(2):485-93. PubMed ID: 8284404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of fine needle aspiration biopsy for breast fibroadenoma diagnosis.
    Szylberg T; Sygut J; Kulig A
    Pol J Pathol; 1997; 48(2):79-86. PubMed ID: 9278103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences].
    Dannert S; Krück W; Schick F; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Jan; 173(1):38-43. PubMed ID: 11225415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ability of subtraction and dynamic MR imaging to detect breast tumors: comparison with ultrasonography and mammography].
    Terao E; Takeuchi H; Iwamura A; Murakami Y; Harada J; Tada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):950-7. PubMed ID: 7971186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of time-to-peak analysis for differentiating malignant and benign breast lesions with dynamic contrast-enhanced MRI.
    Liu F; Kornecki A; Shmuilovich O; Gelman N
    Acad Radiol; 2011 Jun; 18(6):694-704. PubMed ID: 21420329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
    Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
    Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibroadenoma of the breast: a case report.
    Durak MG; Karaman I; Canda T; Balci P; Harmancioğlu O
    Turk Patoloji Derg; 2011; 27(3):254-6. PubMed ID: 21935877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer].
    Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH
    Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of the human female breast. Current status and pathologic correlations.
    Powell DE; Stelling CB
    Pathol Annu; 1988; 23 Pt 1():159-94. PubMed ID: 2838793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS; Tse GM; Lai SY; Yeung DK
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat-suppressed three-dimensional MR imaging of the breast.
    Harms SE; Flamig DP; Hesley KL; Evans WP; Cheek JH; Peters GN; Knox SM; Savino DA; Netto GJ; Wells RB
    Radiographics; 1993 Mar; 13(2):247-67. PubMed ID: 8460218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.